Predictors of cardiovascular events in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention for Endpoint reduction in hypertension study
| Field | Value |
|---|---|
| Model ID | 09-047-02 |
| Model Name | Losartan Intervention For Endpoint (LIFE) Risk Score - Mortality |
| Pubmed ID | 20001655 |
| First Author | Kjeldsen |
| Journal | Blood Pressure |
| Year | 2009 |
| Title | Predictors of cardiovascular events in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention for Endpoint reduction in hypertension study |
| Primary Index Condition | Population Sample |
| Secondary Index Condition | Hypertension |
| Outcome | Mortality |
| Model Sample Size | 9193 |
| Cohort Sample Size | 9193 |
| Number of Events | 438 |
| Follow-Up Duration | Long (>6 months) |
| AUROC | 0.795 |
| Calibration Reported | 1 |
| Covariates | Age in non-smokers (per 10 years); Current smoker; History of atrial fibrillation; History of stroke or transient ischemic attack; Log urinary albumin:creatinine ratio (per 10-fold); Exercise >30 min twice/week; LVH by Cornell product (per 1000 mm-s); Male sex; Serum glucose (mmol/l); Age in current smokers (per 10 years); Prior ischemic heart disease; Serum creatinine (per 10 umol/l) |
| Mesh Terms | To be updated |
| Number of Validations | 0 |